Published :
Tables : 63
Figures : 54
Category : Healthcare
No. of Pages : 243
Report Code : HC-U3353
Veterinary Immunodiagnostics Market is estimated to value over USD 2.4 billion by 2027 end with a CAGR of over 9.4% during the forecast period 2020 to 2027. Increased demand for food products derived from animals, growing livestock and companion animal population, increased disposable income for expenditure on animal healthcare are some of the primary factors contributing to the growth of the market. Furthermore, increased acceptance of animals in developed countries like the United States, growing favourable policies for the usage of better diagnostic products in animals are some other factors positively affecting the veterinary immunodiagnostics market growth. Market Segmentation: By Product Type • Analyzers • Consumables By Animal Type • Livestock • Companion By Technology • Enzyme-Linked Immunosorbent Assay (ELISA) • Radioimmunoassay • Rapid Test • Others By Application • Infectious Disease • Autoimmune Disorder • Endocrinology & Oncology • Bone and Mineral Diseases • Others By End User • Reference Laboratories • Academic and Research Institutes • Veterinary Hospitals and Clinics • Point of Care/ In-house Testing By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into animal type, product, application, technology, end user and region. The product segment is categorised into analysers and consumables. The consumables segment is anticipated to hold the largest veterinary immunodiagnostics market share and this can be credited to a rising insistence for animal diagnostics to prevent the transfer of zoonotic diseases in humans and ensuring that the products derived from animals are of good quality. The animal type segment is fragmented into companion and livestock animals. The livestock animals is anticipated to dominate the market during the forecast period and this is due to the increased investment in the livestock animal healthcare owing to a soaring demand for products based on animals from across the world. Regional Analysis: The North America region is predicted to dominate the market owing to advancements in the healthcare infrastructure, increased disposable income for animal healthcare, rising companion animal population in the United States and improving reimbursement policies for animal healthcare. Competitive Landscape: The prominent players of the market are Abaxisinc., bioMérieux SA, IDEXX Laboratories Inc., Heska Corporation, Virbac SA, Zoetisinc., Randox Laboratories Ltd., Neogen Corporation, Woodley Equipment Company Ltd, Thermo Fisher Scientific Inc., IAGEN N.V. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global veterinary immunodiagnostics market by product type, by animal type, by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Increased demand for food products derived from animals, growing livestock and companion animal population, increased disposable income for expenditure on animal healthcare are some of the primary factors contributing to the growth of the market. Furthermore, increased acceptance of animals in developed countries like the United States, growing favourable policies for the usage of better diagnostic products in animals are some other factors positively affecting the veterinary immunodiagnostics market growth.
Market Segmentation:
By Product Type • Analyzers • Consumables By Animal Type • Livestock • Companion By Technology • Enzyme-Linked Immunosorbent Assay (ELISA) • Radioimmunoassay • Rapid Test • Others By Application • Infectious Disease • Autoimmune Disorder • Endocrinology & Oncology • Bone and Mineral Diseases • Others By End User • Reference Laboratories • Academic and Research Institutes • Veterinary Hospitals and Clinics • Point of Care/ In-house Testing By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into animal type, product, application, technology, end user and region. The product segment is categorised into analysers and consumables. The consumables segment is anticipated to hold the largest veterinary immunodiagnostics market share and this can be credited to a rising insistence for animal diagnostics to prevent the transfer of zoonotic diseases in humans and ensuring that the products derived from animals are of good quality. The animal type segment is fragmented into companion and livestock animals. The livestock animals is anticipated to dominate the market during the forecast period and this is due to the increased investment in the livestock animal healthcare owing to a soaring demand for products based on animals from across the world.
Regional Analysis:
The North America region is predicted to dominate the market owing to advancements in the healthcare infrastructure, increased disposable income for animal healthcare, rising companion animal population in the United States and improving reimbursement policies for animal healthcare.
Competitive Landscape:
The prominent players of the market are Abaxisinc., bioMérieux SA, IDEXX Laboratories Inc., Heska Corporation, Virbac SA, Zoetisinc., Randox Laboratories Ltd., Neogen Corporation, Woodley Equipment Company Ltd, Thermo Fisher Scientific Inc., IAGEN N.V.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global veterinary immunodiagnostics market by product type, by animal type, by technology, by application, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Veterinary Immunodiagnostics Market, By Product Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Analyzers 7.2 Consumables 8. Veterinary Immunodiagnostics Market, By Animal Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Livestock 8.1.1 Cattle 8.1.2 Pigs 8.1.3 Poultry 8.1.4 Others 8.2 Companion 8.2.1 Feline 8.2.2 Canine 8.2.3 Equine 8.2.4 Others 9. Veterinary Immunodiagnostics Market, By Technology Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Enzyme-Linked Immunosorbent Assay (ELISA) 9.1.1 Chemiluminescence Immunoassay 9.1.2 Fluorescent Immunoassay 9.1.3 Colorimetric Immunoassay 9.2 Radioimmunoassay 9.3 Rapid Test 9.4 Others 10. Veterinary Immunodiagnostics Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 10.1 Infectious Disease 10.2 Autoimmune Disorder 10.3 Endocrinology & Oncology 10.4 Bone and Mineral Diseases 10.5 Others 11. Veterinary Immunodiagnostics Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 11.1 Reference Laboratories 11.2 Academic and Research Institutes 11.3 Veterinary Hospitals and Clinics 11.4 Point of Care/ In-house Testing 12. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1. U.S. 12.2.2. Canada 12.2.3. Mexico 12.2.4. Rest of North America 12.3 Market Size (USD Mn) Forecast for North America 2020-2027 13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Regional Market Trends 13.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 13.3.1. Brazil 13.3.2. Venezuela 13.3.3. Argentina 13.3.4. Rest of Latin America 13.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 14.2.1. Germany 14.2.2. U.K 14.2.3. France 14.2.4. Italy 14.2.5 Switzerland 14.2.6. Spain 14.2.7. Russia 14.2.8. Poland 14.2.9. Rest of Western Europe 14.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1 Introduction 15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 15.2.1 Japan 15.2.2 China 15.2.3 Singapore 15.2.4 Korea 15.2.5 India 15.2.6 Australia and New Zealand 15.2.7 ASEAN 15.2.8 Rest of Asia Pacific 15.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 16.1 Introduction 16.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 16.2.1 UAE 16.2.2 South Africa 16.2.3 Egypt 16.2.4 Saudi Arabia 16.2.5 Rest of MEA 16.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 17.1 Abaxisinc 17.1.1. Company Overview (HQ, Business Segments, Employee Strength) 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2 bioMérieux SA 17.2.1. Company Overview (HQ, Business Segments, Employee Strength) 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3 IDEXX Laboratories Inc. 17.3.1. Company Overview (HQ, Business Segments, Employee Strength) 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4 Heska Corporation 17.4.1. Company Overview (HQ, Business Segments, Employee Strength) 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5 Virbac SA 17.5.1. Company Overview (HQ, Business Segments, Employee Strength) 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6 Zoetisinc. 17.6.1. Company Overview (HQ, Business Segments, Employee Strength) 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7 Randox Laboratories Ltd. 17.7.1. Company Overview (HQ, Business Segments, Employee Strength) 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8 Neogen Corporation 17.8.1. Company Overview (HQ, Business Segments, Employee Strength) 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9 Woodley Equipment Company Ltd 17.9.1. Company Overview (HQ, Business Segments, Employee Strength) 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10 Thermo Fisher Scientific Inc. 17.10.1. Company Overview (HQ, Business Segments, Employee Strength) 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 17.11 IAGEN N.V 17.11.1. Company Overview (HQ, Business Segments, Employee Strength) 17.11.2. Product Portfolio 17.11.3. SWOT Analysis 17.11.4. Financial Overview 17.11.5. Strategic Overview 18. Impact of COVID-19 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. Competitive Intelligence and Competitive Matrix 19.1 Competitive Intelligence 19.2 Competitive Matrix 20. Major Deals and Strategic Alliances Analysis 20.1 Joint ventures 20.2 Mergers and acquisitions 20.3 Licensing and partnerships 20.4 Technology Collaborations 20.5 Strategic Divestments 20.6 Market Entry Strategies 21. Relevant Case Studies and Latest News Updates 22. Research Sources and List of Primary Contacts of this Study 23. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics